[HTML][HTML] Biomaterials: foreign bodies or tuners for the immune response?

E Mariani, G Lisignoli, RM Borzì… - International journal of …, 2019 - mdpi.com
The perspectives of regenerative medicine are still severely hampered by the host response
to biomaterial implantation, despite the robustness of technologies that hold the promise to …

Bone tissue engineering: recent advances and challenges

AR Amini, CT Laurencin… - Critical Reviews™ in …, 2012 - dl.begellhouse.com
The worldwide incidence of bone disorders and conditions has trended steeply upward and
is expected to double by 2020, especially in populations where aging is coupled with …

Immune responses to implants–a review of the implications for the design of immunomodulatory biomaterials

S Franz, S Rammelt, D Scharnweber, JC Simon - Biomaterials, 2011 - Elsevier
A key for long-term survival and function of biomaterials is that they do not elicit a detrimental
immune response. As biomaterials can have profound impacts on the host immune …

Biodegradable polymeric nanoparticles based drug delivery systems

A Kumari, SK Yadav, SC Yadav - Colloids and surfaces B: biointerfaces, 2010 - Elsevier
Biodegradable nanoparticles have been used frequently as drug delivery vehicles due to its
grand bioavailability, better encapsulation, control release and less toxic properties. Various …

Curcumin delivery and co-delivery based on nanomaterials as an effective approach for cancer therapy

M Pourmadadi, P Abbasi, MM Eshaghi… - Journal of Drug Delivery …, 2022 - Elsevier
Throughout the world, cancer is one of the main causes of mortality, threatening the public
health in many countries. As a result, cancer therapy researchers are paying increasing …

Biomaterials/tissue interactions: possible solutions to overcome foreign body response

JM Morais, F Papadimitrakopoulos, DJ Burgess - The AAPS journal, 2010 - Springer
In recent years, a variety of biomaterial implantable devices has been developed. Of
particular significance to pharmaceutical sciences is the progress made on the development …

Nano/micro technologies for delivering macromolecular therapeutics using poly (D, L-lactide-co-glycolide) and its derivatives

RC Mundargi, VR Babu, V Rangaswamy… - Journal of Controlled …, 2008 - Elsevier
Biodegradable nano/microparticles of poly (d, l-lactide-co-glycolide)(PLGA) and PLGA-
based polymers are widely explored as carriers for controlled delivery of macromolecular …

Biocompatible materials for continuous glucose monitoring devices

SP Nichols, A Koh, WL Storm, JH Shin… - Chemical …, 2013 - ACS Publications
Diabetes mellitus is a worldwide epidemic characterized by chronic hyperglycemia that
results from either a deficiency or tolerance in insulin. 1 In the United States, 8.3% of the …

A review of the biocompatibility of implantable devices: current challenges to overcome foreign body response

Y Onuki, U Bhardwaj… - Journal of diabetes …, 2008 - journals.sagepub.com
In recent years, a variety of devices (drug-eluting stents, artificial organs, biosensors,
catheters, scaffolds for tissue engineering, heart valves, etc.) have been developed for …

Drug/device combinations for local drug therapies and infection prophylaxis

P Wu, DW Grainger - Biomaterials, 2006 - Elsevier
Combination devices—those comprising drug releasing components together with
functional prosthetic implants—represent a versatile, emerging clinical technology promising …